PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-120

  1. 48 Posts.
    lightbulb Created with Sketch. 4
    It is for rhematoid arthritis, not osteo arthritis. Very different diseases.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.